Literature DB >> 14654650

Neurosarcoid presents differently in children than in adults.

Robert J Baumann1, William C Robertson.   

Abstract

BACKGROUND: Neurosarcoid is seldom recognized in children. In the absence of any large pediatric series, it has been assumed that the presenting signs and symptoms are identical in adults and children.
OBJECTIVE: To test the hypothesis that childhood neurosarcoid differs in presenting signs and symptoms from neurosarcoid in adults.
METHODS: We tabulated the initial neurologic signs and symptoms in all reported cases of childhood sarcoid with evidence of central nervous system involvement. These data then were compared with published studies of adult neurosarcoid.
RESULTS: Twenty-nine cases (from the English, French, and German literature) had descriptions of presenting signs and symptoms. Ages were 3 months to 18 years; 48% (14 of 29) presented before 13 years. Seizures were the most common presenting symptom (38%, 11 of 29), and 73% of these children (8 of 11) were <13 years old at presentation. Twenty-one percent (6 of 29) had cranial nerve involvement at presentation, and all were >or=12 years old. Twenty-one percent (6 of 29) had hypothalamic dysfunction. Five children presented with headache, 4 with motor signs, and 3 with papilledema. Twenty-four percent (7 of 29) had mass lesions on imaging.
CONCLUSIONS: Children with neurosarcoid present differently than do adults. Children are more likely to have seizures, less likely to have cranial nerve palsies, and perhaps more likely to have a space-occupying lesion. Our analysis of the cases available for review in the published literature suggests that children evolve to an adult pattern as they progress through adolescence.

Entities:  

Mesh:

Year:  2003        PMID: 14654650     DOI: 10.1542/peds.112.6.e480

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

Review 1.  Pediatric sellar and suprasellar lesions.

Authors:  Jason W Schroeder; L Gilbert Vezina
Journal:  Pediatr Radiol       Date:  2011-01-26

Review 2.  The puzzling clinical spectrum and course of juvenile sarcoidosis.

Authors:  Andrew Fretzayas; Maria Moustaki; Olga Vougiouka
Journal:  World J Pediatr       Date:  2011-05-15       Impact factor: 2.764

Review 3.  Treating Immune-Related Epilepsy.

Authors:  Sonal Bhatia; Sarah E Schmitt
Journal:  Curr Neurol Neurosci Rep       Date:  2018-02-14       Impact factor: 5.081

Review 4.  Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis.

Authors:  Marianna Spatola; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2017-06       Impact factor: 5.710

5.  Childhood sarcoidosis: Louisiana experience.

Authors:  Abraham Gedalia; Tahir A Khan; Avinash K Shetty; Victoria R Dimitriades; Luis R Espinoza
Journal:  Clin Rheumatol       Date:  2015-01-24       Impact factor: 2.980

6.  Epilepsy associated with systemic autoimmune disorders.

Authors:  Orrin Devinsky; Adam Schein; Souhel Najjar
Journal:  Epilepsy Curr       Date:  2013-03       Impact factor: 7.500

7.  Pituitary Sarcoidosis in a Pediatric Patient Successfully Treated With Adalimumab and Methotrexate.

Authors:  D Sofia Villacis-Nunez; Amit Thakral
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec

8.  Sarcoidosis presenting with hearing loss and granulomatous interstitial nephritis in an adolescent.

Authors:  Michelle N Rheault; Juan C Manivel; Samuel C Levine; Alan R Sinaiko
Journal:  Pediatr Nephrol       Date:  2006-06-30       Impact factor: 3.651

9.  Clinical and radiological features of pituitary stalk lesions in children and adolescents.

Authors:  Sung Chul Yoon; Choong Ho Shin; Sei Won Yang; Seong Yong Lee
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-12-31

10.  Childhood sarcoidosis: A rare but fascinating disorder.

Authors:  Avinash K Shetty; Abraham Gedalia
Journal:  Pediatr Rheumatol Online J       Date:  2008-09-23       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.